Mitomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma
β Scribed by Philip D. Bonomi; Govind Chandra; Arthur H. Rossof; David Klaassen
- Book ID
- 112377473
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 352 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Thirtyβtwo patients with hepatic metastases colorectal carcinoma were treated with hepatic artery infusion (HAI) employing 5βfluorouracil (5βFU) and mitomycinβC (mitoβC). Catheters were placed percutaneously via the femoral artery. Two schedules were employed: (I) 5βFU 1,200 mg/m^2^ IA
A Prospective Randomized Trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and Vincristine (MOF) Versus MOF Plus Streptozotocin (MOF-Strep) A prospective randomized trial evaluated semustine (Methyl CCNU) 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep) in 75 patients
Thirty-eight patients with metastatic colorecal carcinoma were treated with 5-fluorouracil (5-FU), and 38 patients were treated with the combination of 5-FU, cyclophosphamide, and methotrexate. In terms of percent response, response duration, and survival there was no apparent difference between the